Development and Testing of Nutritional Algorithms (NACHO)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDana-Farber Cancer Institute
About this trial
The goal of this research study is to develop a nutrition algorithm to optimize nutritional status and improve quality of life during for participants who are completing or have completed cancer treatment.
The name of the intervention used in this research study is:
Nutrition Algorithm for Cancer Health Outcomes (NACHO) (a technology-based platform that houses the algorithms for the person-centered nutrition program)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Current member of adult PFAC
> 18 years old
> 18 years old
Able to speak and read English
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Nutrition Algorithm
BehavioralA technology-based platform for a person-centered nutrition program, providing suggested foods and recipes from dietitians.
Treatment groups
130 Participants
are divided into 1 treatment groupGroup A: Nutrition Algorithm (NACHO)Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Nutrition Algorithm
Primary study endpoint is development of a nutrition algorithm using the Cancer Nutrition Consortium (CNC) study findings and iteratively refine through an expert Dana-Farber Cancer Institute dietary panel along with consultations from oncology clinicians as needed and feedback from a panel of 4-6 Patient and Family Advisory Council (PFAC) members. Specific to data analyses, chi square, fisher's exact tests, and linear regression will be used to evaluate characteristics associated with changes in taste and different food preferences over time. Findings will inform the development of the algorithms.
Time frame
12 monthsSecondary outcomes
1
Acceptability of Nutrition Algorithm for Cancer Health Outcomes (NACHO) Program
Assessed using the System Usability Scale (SUS), a 10-item instrument with scores that range from 0-100 with higher scores representing greater usability. Acceptability is defined as a SUS score of \>70.
Time frame
Up to 8 months2
Participant Satisfaction
Assessed using the Acceptability e-Scale (AES), a six-item scale that measures how easy, enjoyable, understandable, and helpful the intervention is. Total scores range from 6-30 with higher scores representing greater acceptability. Acceptability is defined as a AES score of \>24.
Time frame
Up to 8 months3
Panel member characteristics (Aims 1a, 1b, 2a, 2b) - Age
Age group (i.e., 18-29, 30-39, 40-49, 50-59, 60-69, 70-79, 80+)
Time frame
Up to 12 months4
Panel member characteristics (Aims 1a, 1b, 2a, 2b) - Gender identity
Gender identity (i.e., female, male, other\_\_\_\_, prefer not to answer)
Time frame
Up to 12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Dana-Farber Cancer Institute
Lead sponsor
Cancer Nutrition Consortium Inc.
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: